This profile was last updated on . .
Is this you? Claim your profile.
BAL PHARMA LIMITED
Welcome to :: Bal Pharma :: - Contact Us
Bal Pharma bets big on Japan Pharma Market - Pharma & Bio Ingredients
Of the $60 billion Japanese pharmaceutical market, generic drugs constitute only 5-7 per cent at present, whereas they account for about 60 per cent of all prescription drug sales in the West.
Now that the Japanese government has started promoting the more affordable generic drugs, especially for those receiving free medical care under the welfare schemes, it is estimated that generics will account for about 20 per cent of its pharmaceutical market in a span of two years.
Siroya said Ebastine's global sales are estimated to be $350 million, of which Japan accounts for around $100 million.
Ebastine is coming off patent by next year, and "this is where we stand to gain",
pharmabiz.com: India's most comprehensive pharma portal
TransForm Solution Pvt Ltd